Overview
Tyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in FGFR biology. The Company's in-house precision medicine platform, SNÅP, enables the rapid and precise refinement of structural drug design through iterative molecular SNÅPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. TYRA's initial focus is on applying its accelerated small molecule drug discovery engine to develop therapies in targeted oncology and genetically defined conditions. TYRA is based in Carlsbad, CA.
Latest Quarterly Earnings
News Releases
Events
Nov 14, 2023 8:30 AM EST
Sep 27, 2023 10:20 AM EDT
Jun 7 - Jun 9, 2023
Presentation
Scientific Posters, Presentations and Publications
November 3, 2023
October 15, 2023
October 12, 2023
October 12, 2023
